On Wednesday, Guggenheim maintained a Buy rating on shares of Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE) and increased the price target to $110 from the previous $95. The firm's optimism ...

On Wednesday, Guggenheim maintained a Buy rating on shares of Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE) and increased the price target to $110 from the previous $95. The firm's optimism is ...

As previously reported, Canaccord initiated coverage of Apogee Therapeutics (APGE) with a Buy rating and $89 price target Apogee is a “significant player” in the immunology and inflammatory ...

As of 2:59 PM EST. Market Open.

After hours: November 25 at 4:20 PM EST Loading Chart for APGE ...

152.4 x 304.8 cm. (60 x 120 in.) ...